VISTAKON (senofilcon A) Brand Contact Lenses
Vistakon, Division of Johnson & Johnson Vision Car · Decision date Oct 16, 2026
What did the FDA decide?
The FDA record P040045/S147, decided October 16, 2026 under decision code OK30, is a 30-Day Notice filed for Vistakon (senofilcon A) Brand Contact Lenses in the soft extended-wear lens category (product code LPM, Ophthalmic). The stated change is the addition of an alternate raw material supplier for the color additive used in the manufacturing process for lens visible handling, at facilities in Jacksonville, Florida and Limerick, Ireland. The supplement number ties the filing to PMA P040045 as a supplement, not as an original approval of the device system.
The notice is classified as a process change covering manufacturer, sterilizer, packager or supplier. The source statement gives the supplier addition as the reported purpose; it does not present independent proof of safety or clinical effectiveness, and none should be read into the decision code. Absent from the supplied fields are the identity of the added supplier, the specifications of the color additive, and the validation data supporting the change.
FDA approval order statement
addition of alternate raw material supplier for the color additive used in the manufacturing process for Vistakon (senofilcon A) Brand Contact Lenses for lens visible handling, at the manufacturing facilities located in Jacksonville, Florida and Limerick, Ireland
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P040045/S147
- Regulatory pathway
- PMA supplement
- Product code
- LPM
- Decision code
- OK30
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Lenses, soft contact, extended wear.
- Product code
- LPM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P040045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P040045 · Original PMA
VISTAKON (SENOFILCON A) CONTACT LENS, CLEAR AND VISIBILITY TINTED WITH UV BLOCKER
P040045/S145 · Related supplement
VISTAKON (SENOFILCON A) CONTACT LENS, CLEAR AND VISIBILITY TINTED WITH UV BLOCKER
P040045/S147 received
Application receipt date recorded by FDA.
P040045/S146 · Related supplement
VISTAKON (SENOFILCON A) Brand Contact Lenses
P040045/S147 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P040045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Vistakon, Division of Johnson & Johnson Vision Car | PMA approval | Dec 20, 2005 | FDA | |
| Vistakon, Division of Johnson & Johnson Vision Car | PMA supplement | Sep 2, 2026 | FDA | |
VISTAKON (SENOFILCON A) Brand Contact LensesP040045/S146 | Vistakon, Division of Johnson & Johnson Vision Car | PMA supplement | Oct 8, 2026 | FDA |
Explore the linked device profile
Other records with product code LPM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Bausch + Lomb Ultra (samfilcon A) Contact LensesP170035/S021 | Bausch and Lomb, Inc., | PMA supplement | Sep 14, 2026 | FDA |
BIOFINITY (COMFILCON A)P080011/S204 | CooperVision, Inc. | PMA supplement | Sep 2, 2026 | FDA |
| Bausch and Lomb, Inc., | PMA approval | Apr 30, 2018 | FDA | |
BIOFINITY (COMFILCON A)P080011 | CooperVision, Inc. | PMA approval | Nov 19, 2008 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Vistakon, Division of Johnson & Johnson Vision Car
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 7500 Centurion Pkwy., Suite 100 - Erca, Jacksonville, FL, 32256
Sources and methodology
- Original FDA record: P040045/S147
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



